Lipids

L3, also known as 1,19-Bis(2-hexyldecyl)10- [[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate, is a derivative of MC3 that can be exploited for creating lipid nanoparticles (LNPs).

L9, also known as 1, 1'-[[(4-Hydroxybutyl)imino]di-9,1-nonanediyl] bis(2-butyloctanoate), is an ALC-0315 analog used in drug delivery.

L13, also known as 1-Octylnonyl 8-[(2-hydroxyethyl)[4-(nony loxy)-4-oxobutyl]amino]octanoate, may be applied in the generation of lipid nanoparticles (LNPs).

L14, also known as 1-Octylnonyl 8-[(2-hydroxyethyl)[8-[(1-methylnonyl)oxy]-8-oxooctyl]amino]octanoate, is an SM-102 analog used in the formation of lipid nanoparticles (LNPs).

L15, also known as 1-Octylnonyl 8-[[3-[[2-(methylamino)-3,4-dioxo-1-cyclobuten-1-yl]amino] propyl] [8- (nonyloxy)-8-oxooctyl] amino]octanoate, may be employed in the development of lipid nanoparticles (LNPs).

L16, also known as ((3-((2-(methylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)propyl)azanediyl)bis (hexane- 6,1-diyl) bis(2-hexyldecanoate), serves as a component for lipid nanoparticles (LNPs).

MVL5 is a multivalent cationic lipid featuring two linoeyl lipid chains and five charged amino head groups proven to be highly effective for DNA and siRNA delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

iPhos-lipid1 is an ionizable phospholipid analog composed of a phosphate group, a quaternized ammonium group, and three hydrophobic tails. These lipids have been shown to destabilize membranes and assist in drug and mRNA delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

iPhos-lipid3 is an ionizable phospholipid analog composed of one pH-switchable zwitterion, one hydrophobic tail, and two aliphatic ether tails. These lipids have been shown to destabilize membranes and assist in drug and mRNA delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.